HSI1 26,009.46 0.00 --
HSCEI1 8,634.34 0.00 --
Back    Zoom +    Zoom - Block Traded
HSI Ends Up 203 Pts; KUAISHOU-W Dives 11%; mRNA Concept Stocks Swell
2026-08-20 16:35:59
This morning (20th), the HSI opened up 284 pts and hovered near the peak level. It once rallied nearly 350 pts in the afternoon before trimming gains late in the session. The index closed at 25,698, up 203 pts or 0.8%, with turnover at HKD269.119 billion. The HSCEI closed at 8,547, up 76 pts or 0.9%. The HSTECH closed at 4,700 pts, up 18 pts or 0.39%.

Among major dotcoms, KUAISHOU-W (01024.HK) slumped 11.01%, making it the worst-performing blue chip, after the company's 2Q adjusted profit slid 30.3% YoY and Daiwa downgraded the stock to Hold. TENCENT (00700.HK) rose nearly 1%; BABA-W (09988.HK) gained 1.61% ahead of results; BIDU-SW (09888.HK) rebounded 2.45%; JD-SW (09618.HK) mounted 1.69%.

For pharmaceuticals, SBP GROUP (01177.HK) swelled 12.53%, becoming the best-performing blue chip of the day, after its interim profit added 1.4% and far exceeded expectations, prompting bullish comments from multiple brokers. WUXI BIO (02269.HK), INNOVENT BIO (01801.HK), WUXI APPTEC (02359.HK), HANSOH PHARMA (03692.HK) and BEONE MEDICINES (06160.HK) hiked more than 1-3%. HENGRUI PHARMA (01276.HK) bucked the market and dived 9.63% after brokers said its quarterly results missed.

Moderna, Inc. (MRNA.US) leapfrogged 176% overnight after its mRNA cancer vaccine achieved a major breakthrough in late-stage clinical trials. The news boosted innovative drug concept stocks. EVEREST MED (01952.HK) skyrocketed 41.43% to close at HKD33.66, with turnover surging to HKD4.269 billion. CANSINOBIO (06185.HK) jumped up 37.36%; 3D MEDICINES (01244.HK) soared 56.88%; GENSCRIPT BIO (01548.HK) spiked 13.62%; CSPC PHARMA (01093.HK) swelled 9.61% after reporting an almost 1.4x leap in interim profit and raising its DPS by 28.6% to HKD0.18.
~

AASTOCKS Financial News
Website: www.aastocks.com